Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease
Launched by MAYO CLINIC · Mar 7, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special type of compression sock called the Fuzzy Wale compression stockinette to see if it can help patients heal faster after having a transtibial amputation, which is when a leg is amputated below the knee due to a condition called Peripheral Arterial Disease. The goal is to find out if this new sock can reduce healing time and lower medical costs compared to the usual compression stockings that patients currently use.
To participate in this study, you need to be at least 18 years old and scheduled for a transtibial amputation. Both men and women are welcome to join. However, if you have allergies to the materials in the compression sock, are receiving cancer treatment, or are unable to follow care instructions, you may not be eligible. If you join the study, you can expect to wear the Fuzzy Wale sock and have regular check-ups to monitor your healing progress. This study is currently not recruiting participants yet, but it aims to gather important information that could improve care for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years
- • Male and female
- • Transtibial amputation expected.
- • Peripheral arterial disease and Transcutaneous partial pressure of oxygen (TCP02, if performed)
- • Ability of subject to give appropriate consent or have an appropriate representative available to do so.
- Exclusion Criteria:
- • Known allergies to any of the components of the compression.
- • Terminal illness or current cancer therapy with chemotherapy
- • Inability to undergo ongoing care in Rochester.
- • Lack of cognitive ability to follow instructions or monitor residual limb.
- • Vulnerable study population
- • Pregnancy
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Matthew Melin, M.D.
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported